Assessment of the 4-factor score: retrospective analysis of 586 cll patients receiving ibrutinib. A campus cll study. Am J Hematol. 2021.
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects. Br J Haematol. 2021.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials. Am J Hematol. 2021.
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia. Blood Adv. 2021.
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience. Acta Haematol. 2021:1-5..
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2020;383(17):1613-1623.
Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer. 2020.
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis. Cancer. 2019.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ. Biol Blood Marrow Transplant. 2019.
Current and future therapeutic approaches for the treatment of follicular lymphoma. Expert Rev Anticancer Ther. 2018..
Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis?. Acta Haematol. 2018;139(4):240-242..
Clinical implications of the molecular genetics of chronic lymphocytic leukemia. Haematologica. 2013;98(5):675-85..